Scandinavia: Antisera Market 2024

Antisera Market Size in Scandinavia

The Scandinavia antisera market expanded modestly to $X in 2021, increasing by 3% against the previous year. The total consumption indicated prominent growth from 2012 to 2021: its value increased at an average annual rate of +5.2% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, consumption increased by +60.4% against 2015 indices. Over the period under review, the market hit record highs in 2021 and is expected to retain growth in years to come.

Antisera Production in Scandinavia

In value terms, antisera production surged to $X in 2021 estimated in export price. In general, production, however, posted a significant increase. The most prominent rate of growth was recorded in 2013 when the production volume increased by 157% against the previous year. The level of production peaked in 2021 and is expected to retain growth in the immediate term.

Antisera Exports

Exports in Scandinavia

In 2021, approx. X tons of antisera and other blood fractions were exported in Scandinavia; with an increase of 1.8% against the previous year's figure. Overall, exports showed a strong expansion. The pace of growth appeared the most rapid in 2013 with an increase of 47%. Over the period under review, the exports attained the peak figure in 2021 and are expected to retain growth in the near future.

In value terms, antisera exports surged to $X in 2021. In general, exports saw resilient growth. As a result, the exports attained the peak and are likely to continue growth in the immediate term.

Exports by Country

In 2021, Sweden (X tons) represented the largest exporter of antisera and other blood fractions, achieving 59% of total exports. It was distantly followed by Denmark (X tons), achieving a 37% share of total exports. Finland (X tons) followed a long way behind the leaders.

From 2012 to 2021, the most notable rate of growth in terms of shipments, amongst the main exporting countries, was attained by Denmark (with a CAGR of +15.4%), while the other leaders experienced more modest paces of growth.

In value terms, Sweden ($X), Denmark ($X) and Finland ($X) constituted the countries with the highest levels of exports in 2021, together comprising 100% of total exports.

In terms of the main exporting countries, Sweden, with a CAGR of +19.9%, recorded the highest growth rate of the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2021, the export price in Scandinavia amounted to $X per kg, jumping by 33% against the previous year. Over the period under review, the export price, however, showed a pronounced decline. The level of export peaked at $X per kg in 2012; however, from 2013 to 2021, the export prices remained at a lower figure.

There were significant differences in the average prices amongst the major exporting countries. In 2021, the country with the highest price was Denmark ($X per kg), while Finland ($X per kg) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Sweden (+4.5%), while the other leaders experienced mixed trends in the export price figures.

Antisera Imports

Imports in Scandinavia

In 2021, after two years of decline, there was significant growth in supplies from abroad of antisera and other blood fractions, when their volume increased by 10% to X tons. In general, imports posted a strong increase. The pace of growth was the most pronounced in 2017 when imports increased by 66% against the previous year. The volume of import peaked at X tons in 2018; however, from 2019 to 2021, imports failed to regain momentum.

In value terms, antisera imports soared to $X in 2021. Overall, imports showed a resilient expansion. As a result, imports reached the peak and are likely to continue growth in the immediate term.

Imports by Country

In 2021, Denmark (X tons) was the major importer of antisera and other blood fractions, creating 70% of total imports. Sweden (X tons) held the second position in the ranking, followed by Norway (X tons). All these countries together took near 27% share of total imports. Finland (X tons) held a minor share of total imports.

From 2012 to 2021, average annual rates of growth with regard to antisera imports into Denmark stood at +6.3%. At the same time, Norway (+14.8%), Finland (+10.9%) and Sweden (+2.0%) displayed positive paces of growth. Moreover, Norway emerged as the fastest-growing importer imported in Scandinavia, with a CAGR of +14.8% from 2012-2021. Norway (+6.3 p.p.) significantly strengthened its position in terms of the total imports, while Sweden saw its share reduced by -6.5% from 2012 to 2021, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the largest antisera importing markets in Scandinavia were Sweden ($X), Denmark ($X) and Norway ($X), with a combined 87% share of total imports.

Norway, with a CAGR of +11.6%, saw the highest growth rate of the value of imports, in terms of the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in Scandinavia stood at $X per ton in 2021, growing by 5.5% against the previous year. Over the period from 2012 to 2021, it increased at an average annual rate of +2.3%. The growth pace was the most rapid in 2020 when the import price increased by 21%. The level of import peaked at $X per ton in 2016; however, from 2017 to 2021, import prices remained at a lower figure.

Prices varied noticeably country of destination: the country with the highest price was Finland ($X per ton), while Denmark ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Denmark (+4.9%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform